Table 3.
Measures | Distribution, n (%) | ||
---|---|---|---|
All | Naloxone dispensed (any vs. none) | p-value | |
Total | 60 (100.0) | 35 (58.33) | |
Vaccinations | 0.726 | ||
Supportive | 56 (93.3) | 33 (58.9) | |
Not supportive | 4 (6.7) | 2 (50.0) | |
HIV testing | 0.023* | ||
Supportive | 45 (75.0) | 30 (66.7) | |
Not supportive | 15 (25.0) | 5 (33.3) | |
Referral to free HIV testing | 0.088 | ||
Supportive | 58 (96.7) | 35 (60.3) | |
Not supportive | 2 (3.3) | 0 (0.0) | |
Information on safe syringe disposal | 0.233 | ||
Supportive | 59 (98.3) | 35 (59.3) | |
Not supportive | 1 (1.8) | 0 (0.0) | |
Information on safe syringe use | 0.162 | ||
Supportive | 56 (93.3) | 34 (60.7) | |
Not supportive | 4 (6.7) | 1 (25.0) | |
Referrals to medical & social services | 0.946 | ||
Supportive | 53 (88.3) | 31 (58.5) | |
Not supportive | 7 (11.7) | 4 (57.1) | |
Referrals to drug treatment | 0.190 | ||
Supportive | 54 (90.0) | 33 (61.1) | |
Not supportive | 6 (10.0) | 2 (33.3) |